Cannabinoid receptors, what are they and why do they matter?

You've heard about CB1 receptors before, probably in the same breath as "THC binds to your brain." But CB1 isn't the whole story. There's a CB2 receptor too, and a small cluster of other receptors that cannabinoids interact with as well. Let's get into what each of these actually is, where it lives, and why some of them matter a lot more to your actual high than others.

What is a cannabinoid receptor?

Both CB1 and CB2 are G protein-coupled receptors, or GPCRs 1; a type of cell-surface receptor that acts like a doorbell rather than a doorway: activating it doesn't let anything into the cell, it kicks off a chain reaction of internal signaling instead 1. CB1 was first identified in 1988 and cloned in 1990, while CB2 followed a few years later, cloned in 1993 from a human leukemia cell line 2 & 3. Together they form the backbone of your endocannabinoid system, the network your body already uses to help regulate mood, memory, appetite, pain, and immune activity.

CB1: the one behind your high

CB1 is genuinely a landmark discovery in modern neuroscience 4. research has shown it's one of the most abundant GPCRs in the entire brain, meaning your brain has more of these receptors than almost any other type of cell-surface receptor out there 4.‍ ‍

CB1 receptors are concentrated overwhelmingly in the central nervous system, most densely packed into brain regions tied to cognition and memory (the cortex and hippocampus) and motor control (the basal ganglia and cerebellum) 4. That distribution is exactly why THC affects the things it affects: memory, coordination, and your sense of time all map directly onto where these receptors live 5.

CB1 isn't purely a brain receptor, though. Lower levels also show up in peripheral tissues throughout the body including the eyes, reproductive organs, digestive system, adipose (fat) tissue, and sensory neurons 6. This wider distribution helps explain why cannabis affects far more than just your headspace, from appetite to digestion.

At a cellular level, CB1 receptors are mostly found on presynaptic nerve terminals; the sending end of a neuron, right before a signal crosses to the next cell 7. This positioning is deliberate: CB1 acts as a kind of volume control, and when activated, it typically dials down the release of other neurotransmitters, including GABA 7.‍ ‍

THC works because it structurally resembles your body's own natural cannabinoids closely enough to bind directly to CB1 5. Your endocannabinoid system normally produces its own ligands in response to neuronal activity, using them as fast retrograde messengers that travel backward across a synapse to fine-tune signaling in real time 7. THC essentially hijacks that same mailbox, just with a stronger, longer-lasting message than your body typically sends itself.

CB2: the immune system's cannabinoid receptor‍ ‍

Here's where things diverge in an important way. CB2 receptors are found mostly outside the brain, expressed heavily on immune cells: T cells, B cells, macrophages, natural killer cells, and cells throughout the gastrointestinal system 8. Within the immune system, B cells and natural killer cells actually carry the highest concentrations of CB2 of any cell type 9.

CB2 does show up in the central nervous system too, but almost exclusively on microglia; the brain's resident immune cells, rather than on neurons themselves 10. And this is the key distinction worth remembering: because CB2 sits primarily on immune cells rather than the neurons responsible for perception, mood, and memory, activating it doesn't produce the psychoactive effects associated with CB1 11. Researchers studying CB2 in the brain have found that activating it modulates immune activity within the CNS without producing behavioral or psychotropic effects 11.

That makes CB2 a genuinely exciting target for pharmaceutical research. The idea of getting the anti-inflammatory, immune-modulating benefits of cannabinoids without touching the "high" at all. CB2 has been studied for its potential role in conditions like rheumatoid arthritis and Crohn's disease, precisely because of this immune-focused, non-intoxicating profile 8.‍ ‍

Are there other cannabinoid-related receptors?‍ ‍

Yes, and this is where we're going to be upfront about the limits of what's settled science. A handful of other receptors interact with cannabinoids in ways that don't meaningfully shape your actual cannabis experience, so we're not going deep on them here, but they're worth knowing exist:

  • GPR55: sometimes informally nicknamed "CB3," is a receptor that several cannabinoids, including THC, anandamide, and 2-AG, bind to with notable affinity, but its exact role in cannabis's effects on humans is still being actively mapped out 12. Curious readers can dig into the ongoing research directly via the source link below.

  • TRPV1: a receptor better known for detecting heat and pain, is also activated by both CBD and anandamide, and some researchers argue it deserves a seat at the "cannabinoid receptor" table too 13.

  • PPARs (peroxisome proliferator-activated receptors): are a separate class of receptors located inside the cell nucleus, involved in gene expression and fat metabolism, and several cannabinoids interact with them 13.

None of these are established as significant contributors to the recreational cannabis experience the way CB1 clearly is, which is why we're keeping this section brief rather than padding it out with speculative detail.

The bottom line‍ ‍

CB1 and CB2 are two branches of the same system with very different jobs: CB1 sits mostly in the brain and is directly responsible for the psychoactive effects of THC, while CB2 lives mostly on immune cells and shapes inflammation and immune response without getting you high. A handful of other receptors, GPR55, TRPV1, PPARs, round out the picture in ways researchers are still working to fully understand, but they're a footnote to the cannabis experience, not the main story. Understanding CB1 and CB2 specifically is what actually explains what you feel when you consume cannabis, and why CBD and THC can feel so different despite coming from the very same plant.‍ ‍

This is educational content, not medical advice, consult a doctor for medical use.

Sources

  1. Frontiers, Structural insights into cannabinoid receptors CB1 and CB2: determinants of ligand selectivity

  2. PubMed, Structure of a cannabinoid receptor and functional expression of the cloned cDNA (Matsuda et al., Nature, 1990)

  3. ClinicalTrials.gov, CANPAIN Feasibility Study: Pragmatic Real World Trial Investigating CBMP in Chronic Pain Patients

  4. Frontiers, Structural insights into cannabinoid receptors CB1 and CB2: determinants of ligand selectivity

  5. Azarius, Endocannabinoid System Explained: Receptors & Anandamide

  6. USPTO filing, Hydrazone modulators of cannabinoid receptors

  7. Journal of Neuroscience, Structural Domains of the CB1 Cannabinoid Receptor That Contribute to Constitutive Activity and G-Protein Sequestration

  8. USPTO filing, Cannabinoid-2 agonists

  9. British Journal of Pharmacology, Wiley, CB2 receptor-mediated migration of immune cells: it can go either way

  10. ScienceDirect Topics, Cannabinoid 2 Receptor — an overview

  11. British Journal of Pharmacology, Wiley, CB2 receptors in the brain: role in central immune function

  12. National Institute on Drug Abuse (NIDA) Intramural Research Program, Hot Off the Press — April 4, 2024 (GPR55 / "CB3" research summary)

  13. Royal Queen Seeds, Is GPR55 the Third Cannabinoid Receptor?

All posts
Jarno Buiteman

Jarno Buiteman pairs hands-on industry experience with a close eye on the underlying science. After a year working in a coffeeshop, he completed De Coffeeshopcursus through the Trimbos Institute, a training covering how cannabis works in the body, health risks, and the relevant Dutch regulations. For the past two years he's put that grounding to work at Othello Twist, writing content that goes beyond marketing language: backed by peer-reviewed research, transparent about what's still uncertain, and always pointing to a doctor for medical decisions.

https://www.linkedin.com/in/jarnobuiteman/
Previous
Previous

Trichomes: the tiny structures where all your cannabis chemistry actually happens

Next
Next

CBD, what is it exactly? An in-depth look at cannabis' non-high cannabinoid